Evid Invest
Who owns ZBIOWhat ZBIO owns — n/a

Who owns Zenas BioPharma, Inc.?

Institutional ownership of ZBIO from SEC Form 13F filings across 112 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

112

13F holders

$875.0M

value, 2026 filers

57.3%

of shares outstanding (36.2M sh)

25

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of ZBIO's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC9.5M$241.3M0.0%15.1%+4.7%
2FEDERATED HERMES, INC.3.1M$79.1M0.1%4.9%-0.3%
3BlackRock, Inc.2.7M$68.2M0.0%4.3%+31.8%
4Capital International Investors2.5M$63.5M0.0%4%+2.8%
5Polar Capital Holdings Plc2.4M$61.2M0.1%3.8%-5.3%
6WELLINGTON MANAGEMENT GROUP LLP1.6M$40.5M0.0%2.5%+27.9%
7VANGUARD CAPITAL MANAGEMENT LLC1.4M$34.4M0.0%2.1%-45.6%
8BANK OF AMERICA CORP /DE/1.2M$31.2M0.0%2%+217.0%
9PRICE T ROWE ASSOCIATES INC /MD/1.2M$31,1410.0%1.9%+243.4%
10ALLIANCEBERNSTEIN L.P.1.1M$21.6M0.0%1.7%+23.0%
11GEODE CAPITAL MANAGEMENT, LLC882,654$22.4M0.0%1.4%+34.6%
12TWO SIGMA INVESTMENTS, LP815,150$20.7M0.0%1.3%+196.4%
13MILLENNIUM MANAGEMENT LLC660,470$16.8M0.0%1%+38.5%
14Woodline Partners LP590,539$15.0M0.0%0.9%-50.0%
15Balyasny Asset Management L.P.576,717$14.6M0.0%0.9%-13.5%
16SILVERARC CAPITAL MANAGEMENT, LLC509,789$12.9M1.3%0.8%-55.1%
17MARSHALL WACE, LLP323,442$8.2M0.0%0.5%-35.6%
18JENNISON ASSOCIATES LLC314,049$8.0M0.0%0.5%+25.6%
19VANGUARD PORTFOLIO MANAGEMENT LLC304,870$7.7M0.0%0.5%+21.3%
20Sixth Street Partners Management Company, L.P.NEW302,085$7.7M1.3%0.5%new
21CHARLES SCHWAB INVESTMENT MANAGEMENT INC302,085$7.7M0.0%0.5%+34.6%
22NORTHERN TRUST CORP281,140$7.1M0.0%0.4%+44.4%
23GOLDMAN SACHS GROUP INC271,163$6.9M0.0%0.4%-28.9%
24VANGUARD FIDUCIARY TRUST CO254,623$6.5M0.0%0.4%+41.9%
25iA Global Asset Management Inc.215,130$5,4600.1%0.3%-0.3%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.